The expression of lnc-MyD88 (HR = 1.778, 95% CI = 1.086–2.911, P = 0.022), DBIL (HR = 0.749, 95% CI = 0.589–0.953, P = 0.019), AFP (HR = 1.095, 95% CI = 1.030–1.164, P = 0.004), and HBsAg (HR = 0.113, 95% CI = 0.021–0.615, P = 0.012) had potential to distinguish HCC patients from LC patients (Figure 2D). Here, MYD88 is linked to hepatocellular carcinoma.